Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results
Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
Zepbound helps shed more weight than Wegovy, Eli Lilly study says
A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.
KDFW5h
FDA approves Zepbound for obstructive sleep apnea
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...
WHYY1d
Greater Philly’s largest health insurer to restrict coverage for weight loss medications, citing ‘exorbitant costs’
Independence Blue Cross joins other insurance companies in restricting coverage of Wegovy and Ozempic to Type 2 diabetes and ...
STAT2d
What Novo Nordisk’s disappointing trial results mean for the obesity drug market
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...
Yahoo3d
Ozempic, Wegovy Users Behold: Nestle is Creating Frozen Pasta, Pizza and More Just For You
The world’s largest food and beverage company said it plans to launch a frozen food brand that will cater to consumers who ...
Novo Nordisk Shares Plunge After New Obesity Shot Disappoints
Novo Nordisk ’s big bet to improve on the success of its weight-loss drug franchise hit a stumbling block Friday, wiping out ...
Pennsylvania Medicaid spent nearly $300 million on Wegovy and other anti-obesity drugs
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound and other anti-obesity drugs was third-highest in the ...
Maryland Medicaid spent $68M in a year on obesity and diabetes drugs like Ozempic, Wegovy
Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...
Barron's on MSN6d
Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.
Novo says that it has regulatory clearance to buy three key manufacturing sites used to make drugs like Wegovy, its ...